Cargando…

Psychometric Hepatic Encephalopathy Score for the Diagnosis of Minimal Hepatic Encephalopathy in Thai Cirrhotic Patients

The psychometric hepatic encephalopathy score (PHES) is the gold standard for diagnosing minimal hepatic encephalopathy (MHE). Screening for MHE is frequently overlooked in clinical practice due to time constraints. Furthermore, the simplified animal naming test (S-ANT1) is a new simple tool for eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thanapirom, Kessarin, Wongwandee, Monton, Suksawatamnuay, Sirinporn, Thaimai, Panarat, Siripon, Napaporn, Makhasen, Wanwisar, Treeprasertsuk, Sombat, Komolmit, Piyawat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864758/ https://www.ncbi.nlm.nih.gov/pubmed/36675448 http://dx.doi.org/10.3390/jcm12020519

Ejemplares similares

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients
por: Thanapirom, Kessarin, et al.
Publicado: (2017)

Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection
por: Thanapirom, Kessarin, et al.
Publicado: (2015)

Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Stability of hepatitis B virus pregenomic RNA in plasma specimens under various temperatures and storage conditions
por: Rattanachaisit, Pakkapon, et al.
Publicado: (2021)

Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial
por: Komolmit, Piyawat, et al.
Publicado: (2017)

Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study
por: Komolmit, Piyawat, et al.
Publicado: (2017)

Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2020)

Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2021)

Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study
por: Komolmit, Piyawat, et al.
Publicado: (2020)

The association between vitamin D receptor polymorphism and phases of chronic hepatitis B infection in HBV carriers in Thailand
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Association between Vitamin D Receptor Single-Nucleotide Polymorphisms and Colorectal Cancer in the Thai Population: A Case-Control Study
por: Suksawatamnuay, Sirinporn, et al.
Publicado: (2020)

Hepatic Necrosis Mimicking Infiltrative Masses in Acute Budd-Chiari Syndrome With Hereditary Protein C Deficiency
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

Hepatopleural Fistula with Empyema Thoracis: A Rare Complication of Autosomal Dominant Polycystic Kidney Disease
por: Maytapa, Jeerawat, et al.
Publicado: (2018)

Polymyositis Associated with Hepatitis B Virus Cirrhosis and Advanced Hepatocellular Carcinoma
por: Thanapirom, Kessarin, et al.
Publicado: (2014)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030
por: Sintusek, Palittiya, et al.
Publicado: (2022)

Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

Autoimmune Hepatitis Triggered by COVID-19 Vaccine: The First Case From Inactivated Vaccine
por: Mekritthikrai, Krittaya, et al.
Publicado: (2022)

Acute liver failure and death predictors in patients with dengue-induced severe hepatitis
por: Teerasarntipan, Tongluk, et al.
Publicado: (2020)

Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography
por: Teeratorn, Nicha, et al.
Publicado: (2019)

Nephrotic Syndrome Induced by Lenvatinib Treatment for Hepatocellular Carcinoma
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Circulating Cytokines and Histological Liver Damage in Chronic Hepatitis B Infection
por: Poovorawan, Kittiyod, et al.
Publicado: (2013)

Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions
por: Treeprasertsuk, Sombat, et al.
Publicado: (2015)

Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study
por: Thanapirom, Kessarin, et al.
Publicado: (2017)

Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy
por: Zhou, Yuqing, et al.
Publicado: (2016)

Reduced Cortical Complexity in Cirrhotic Patients with Minimal Hepatic Encephalopathy
por: Chen, Qiu-Feng, et al.
Publicado: (2020)

Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy
por: Peng, Ying, et al.
Publicado: (2021)

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Nutritional Deficiencies and Clinical Practices in Decompensated Cirrhotics With Hepatic Encephalopathy
por: Panchani, Nishah N, et al.
Publicado: (2022)

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients
por: Ventura-Cots, Meritxell, et al.
Publicado: (2017)

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ltd1cs9rjq1994arqqpop6legf